AU1093995A - Surface membrane proteins and their effect on immune response - Google Patents

Surface membrane proteins and their effect on immune response

Info

Publication number
AU1093995A
AU1093995A AU10939/95A AU1093995A AU1093995A AU 1093995 A AU1093995 A AU 1093995A AU 10939/95 A AU10939/95 A AU 10939/95A AU 1093995 A AU1093995 A AU 1093995A AU 1093995 A AU1093995 A AU 1093995A
Authority
AU
Australia
Prior art keywords
peptide
protein
cells
binding
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10939/95A
Other languages
English (en)
Inventor
Carol Clayberger
Alan M. Krensky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of AU1093995A publication Critical patent/AU1093995A/en
Assigned to BOARD OF TRUSTEES FOR THE LELAND STANFORD JUNIOR UNIVERSITY, THE reassignment BOARD OF TRUSTEES FOR THE LELAND STANFORD JUNIOR UNIVERSITY, THE Amend patent request/document other than specification (104) Assignors: BOARD OF TRUSTEES FOR THE LELAND STANFORD JUNIOR UNIVERSITY, THE
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU10939/95A 1993-11-10 1994-11-10 Surface membrane proteins and their effect on immune response Abandoned AU1093995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15049393A 1993-11-10 1993-11-10
US150493 1993-11-10
PCT/US1994/012985 WO1995013288A1 (en) 1993-11-10 1994-11-10 Surface membrane proteins and their effect on immune response

Publications (1)

Publication Number Publication Date
AU1093995A true AU1093995A (en) 1995-05-29

Family

ID=22534794

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10939/95A Abandoned AU1093995A (en) 1993-11-10 1994-11-10 Surface membrane proteins and their effect on immune response

Country Status (5)

Country Link
EP (1) EP0730604A4 (ja)
JP (1) JPH09508617A (ja)
AU (1) AU1093995A (ja)
CA (1) CA2176208A1 (ja)
WO (1) WO1995013288A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011834B1 (en) * 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US6436903B1 (en) * 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
JP4615630B2 (ja) * 1996-09-18 2011-01-19 ヴィルドナー，ゲルヒルト 自己免疫疾患の診断薬と治療薬となるペプチド類
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
ATE352556T1 (de) 1997-04-11 2007-02-15 Sangstat Medical Corp Zytomodulierende lipophile peptide zur modulation der immunsystemaktivität und hemmung von entzündungen
EP1525216A4 (en) 2002-01-24 2009-07-08 Sangstat Medical Corp COMBINATION THERAPY FOR THE TREATMENT OF HIV INFECTION
WO2005053727A2 (en) 2003-11-29 2005-06-16 Sangstat Medical Corporation Pharmaceutical compositions for bioactive peptide agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides

Also Published As

Publication number Publication date
WO1995013288A1 (en) 1995-05-18
EP0730604A4 (en) 1998-01-07
EP0730604A1 (en) 1996-09-11
CA2176208A1 (en) 1995-05-18
JPH09508617A (ja) 1997-09-02

Similar Documents

Publication Publication Date Title
Thomas The leukocyte common antigen family
Clevers et al. The T cell receptor/CD3 complex: a dynamic protein ensemble
Kaye et al. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor
JP4170389B2 (ja) 蛋白質チロシンキナーゼキメラによる細胞性免疫の再指示
Peltz et al. Cloned and expressed human Fc receptor for IgG mediates anti-CD3-dependent lymphoproliferation.
US20060171954A1 (en) Antigen specific activated T-lymphocytes, detection and use
US5888512A (en) Lymphocyte activity regulation by HLA peptides
JP3025271B2 (ja) 無細胞ｔ細胞抗原レセプターおよびその臨床的利用
Ostrov et al. T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.
MX2012006199A (es) Agentes para tratamiento de enfermedad.
Davidson et al. Distribution and immunoregulatory properties of antisecretory factor
AU1093995A (en) Surface membrane proteins and their effect on immune response
WO1995026979A1 (en) Cytotoxic t-cell lymphocyte ('ctl') activity regulation by class i mhc peptides
HU224137B1 (hu) Kiméra-receptorokat kódoló DNS-molekulák, a DNS-molekulákat hordozó vektorok és a DNS-molekulákat expresszáló sejtek
Devaux et al. Generation of monoclonal antibodies against soluble human T cell receptor polypeptides
Osborn et al. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2.
CA2220098A1 (en) Cd6 ligand
EP0579747A4 (en) Method of modulating mammalian t-cell response
AU697246B2 (en) Method for identifying individuals suffering from a cellular abnormality
JPH10511985A (ja) ヒトグルタミン酸デカルボキシラーゼ（ｇａｄ）からの自己反応性ペプチド
WO1998006838A1 (en) Methods and means for modifying complement activation
Hayball et al. The immune function of MHC class II molecules mutated in the putative superdimer interface
KR0167016B1 (ko) 항원 특이적인 활성화된 t 림프구, 이것의 검출 및 사용방법
GAMMA-DElTA et al. DISTINCT MOlECULAR FORMS OF HUMAN
Straus Heterogeneity of function in human CD4-8-T-cell clones from the periphery